HIV/AIDS: Treatment and Life Expectancy
No cure exists for HIV/AIDS. However, antiretroviral therapy (ART) transforms HIV into a manageable chronic condition.
ART Benefits
- Suppresses viral load to undetectable (<50 copies/mL)
- Preserves/restores CD4+ T-cell count
- Prevents opportunistic infections and AIDS-defining illnesses
- U=U: Undetectable = Untransmittable (sexual transmission)
- Near-normal life expectancy if started early and adhered to
Current Regimens
Single-tablet regimens (STRs) with integrase inhibitors (bictegravir, dolutegravir) + NRTIs are first-line: high efficacy, high barrier to resistance, few side effects.
Challenges
- Lifelong adherence required
- Drug resistance if adherence fails
- Long-term toxicities (renal, bone, metabolic, cardiovascular)
- Stigma, access disparities, cost
- Reservoirs persist; cure strategies (shock-and-kill, gene editing) in research
With modern ART, a 20-year-old diagnosed today can expect to live into their 70s—approaching general population life expectancy.
HIV & AIDS - Related Articles
- Understanding the History of AIDS: Early Identification and Treatment
- AIDS and HIV: How Immune Destruction Leads to Opportunistic Diseases
- Understanding HIV and AIDS: Transmission and Prevention
- AIDS and Immune System Collapse: Opportunistic Infections, Cancers, and Systemic Effects
- Understanding Life with HIV: Management, Treatment & Outlook
- Understanding HIV: Structure and How it Attacks the Immune System
- HIV and Influenza: Increased Risk and Severity
